Disease-specific quality of life evaluation and its determinants in Cushing’s syndrome: what have we learnt?

Author： Badia X.   Valassi E.   Roset M.   Webb S.  

Publisher： Springer Publishing Company

ISSN： 1386-341X

Source： Pituitary, Vol.17, Iss.2, 2014-04, pp. : 187-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Role of Biologics and Other Therapies in Stricturing Crohn’s Disease: What Have We Learnt So Far?

By  

Digestion, Vol. 77, Iss. 1, 2008-02 ,pp. : 38-47

Karger

Access to resources Recommend Favorite

Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing’s disease

By Pas R.   Bruin C.   Pereira A.   Romijn J.   Netea-Maier R.   Hermus A.   Zelissen P.   Jong F.   Lely A.   Herder W.   Webb S.   Lamberts S.   Hofland L.   Feelders R.  

Pituitary, Vol. 16, Iss. 4, 2013-12 ,pp. : 536-544

Springer Publishing Company

Access to resources Recommend Favorite

Cushing’s disease

By De Martin Martina   Giraldi Francesca   Cavagnini Francesco  

Pituitary, Vol. 9, Iss. 4, 2006-12 ,pp. : 279-287

Springer Publishing Company

Access to resources Recommend Favorite

Generic and Disease-Specific Measures of Quality of Life in Patients with Mild Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 30, Iss. 4, 2010-10 ,pp. : 327-333

Karger

Access to resources Recommend Favorite

Combination therapy for Cushing’s disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole?

By Barbot M.   Albiger N.   Ceccato F.   Zilio M.   Frigo A.   Denaro L.   Mantero F.   Scaroni C.  

Pituitary, Vol. 17, Iss. 2, 2014-04 ,pp. : 109-117

Springer Publishing Company

Access to resources Recommend Favorite